Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Myofibrillar integrity" refers to the preservation of structure and function within myofibrils—the contractile units composed primarily of actin, myosin, tropomyosin-troponin complexes, titin, nebulin, desmin and other associated proteins found in striated muscle cells[2][3]. This concept encompasses the maintenance of ordered secondary structures (such as α-helices), prevention of oxidative damage to amino acid side chains (e.g., carbonylation), stabilization against denaturation during stressors like freeze-thaw cycles or processing conditions,[1] and retention of solubility/emulsifying properties important both physiologically and industrially.[4] Loss or disruption leads to impaired muscle function or reduced meat product quality but does not represent an individual molecular target amenable to direct pharmacological intervention.
Not applicable as there are no direct drugs targeting this entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myofibrillar protein integrity (MP integrity).